Telo Retained Earnings vs Cash And Short Term Investments Analysis

TELO Stock  CAD 0.12  0.01  7.69%   
Telo Genomics financial indicator trend analysis is much more than just breaking down Telo Genomics Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telo Genomics Corp is a good investment. Please check the relationship between Telo Genomics Retained Earnings and its Cash And Short Term Investments accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Retained Earnings vs Cash And Short Term Investments

Retained Earnings vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telo Genomics Corp Retained Earnings account and Cash And Short Term Investments. At this time, the significance of the direction appears to have pay attention.
The correlation between Telo Genomics' Retained Earnings and Cash And Short Term Investments is -0.73. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Telo Genomics Corp, assuming nothing else is changed. The correlation between historical values of Telo Genomics' Retained Earnings and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Telo Genomics Corp are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Retained Earnings i.e., Telo Genomics' Retained Earnings and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.73
Relationship DirectionNegative 
Relationship StrengthWeak

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Telo Genomics Corp balance sheet. This account contains Telo Genomics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Telo Genomics Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Telo Genomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telo Genomics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Issuance Of Capital Stock is likely to climb to about 3.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.6 M in 2024.
 2021 2022 2023 2024 (projected)
Cost Of Revenue57.0K33.1K38.1K55.4K
Research Development1.1M1.4M1.6M834.8K

Telo Genomics fundamental ratios Correlations

0.080.97-0.93-0.730.95-0.310.950.680.110.990.350.820.97-0.13-0.660.430.430.590.790.09-0.11-0.49-0.69-0.57-0.49
0.08-0.190.16-0.47-0.1-0.13-0.10.631.0-0.020.280.31-0.070.91-0.530.230.230.540.350.720.77-0.04-0.26-0.39-0.04
0.97-0.19-0.96-0.60.96-0.260.960.5-0.150.980.280.730.97-0.36-0.510.360.360.430.68-0.1-0.31-0.48-0.61-0.45-0.48
-0.930.16-0.960.69-0.980.38-0.98-0.440.12-0.97-0.12-0.73-0.950.360.54-0.51-0.51-0.48-0.770.190.180.360.740.610.36
-0.73-0.47-0.60.69-0.730.62-0.73-0.66-0.51-0.73-0.06-0.88-0.69-0.230.86-0.82-0.82-0.81-0.96-0.16-0.470.370.940.940.37
0.95-0.10.96-0.98-0.73-0.421.00.44-0.060.980.10.780.96-0.34-0.580.590.590.490.79-0.21-0.12-0.53-0.78-0.64-0.53
-0.31-0.13-0.260.380.62-0.42-0.42-0.11-0.16-0.350.38-0.49-0.40.10.38-0.73-0.73-0.33-0.590.26-0.340.280.710.70.28
0.95-0.10.96-0.98-0.731.0-0.420.44-0.060.980.10.780.96-0.34-0.580.590.590.490.79-0.21-0.12-0.53-0.78-0.64-0.53
0.680.630.5-0.44-0.660.44-0.110.440.660.570.610.680.580.52-0.710.150.150.720.660.730.21-0.12-0.42-0.43-0.12
0.111.0-0.150.12-0.51-0.06-0.16-0.060.660.010.280.34-0.030.9-0.560.260.260.570.390.720.77-0.05-0.3-0.43-0.05
0.99-0.020.98-0.97-0.730.98-0.350.980.570.010.250.80.97-0.24-0.630.50.50.550.79-0.05-0.14-0.52-0.73-0.6-0.52
0.350.280.28-0.12-0.060.10.380.10.610.280.250.180.180.47-0.46-0.4-0.40.480.090.73-0.170.030.150.170.03
0.820.310.73-0.73-0.880.78-0.490.780.680.340.80.180.80.1-0.780.660.660.70.870.210.32-0.54-0.79-0.72-0.54
0.97-0.070.97-0.95-0.690.96-0.40.960.58-0.030.970.180.8-0.31-0.520.440.440.440.75-0.06-0.2-0.48-0.67-0.54-0.48
-0.130.91-0.360.36-0.23-0.340.1-0.340.520.9-0.240.470.1-0.31-0.47-0.01-0.010.520.120.830.690.18-0.01-0.160.18
-0.66-0.53-0.510.540.86-0.580.38-0.58-0.71-0.56-0.63-0.46-0.78-0.52-0.47-0.61-0.61-0.97-0.84-0.41-0.440.320.760.770.32
0.430.230.36-0.51-0.820.59-0.730.590.150.260.5-0.40.660.44-0.01-0.611.00.530.76-0.280.54-0.47-0.92-0.92-0.47
0.430.230.36-0.51-0.820.59-0.730.590.150.260.5-0.40.660.44-0.01-0.611.00.530.76-0.280.54-0.47-0.92-0.92-0.47
0.590.540.43-0.48-0.810.49-0.330.490.720.570.550.480.70.440.52-0.970.530.530.820.460.45-0.14-0.69-0.74-0.14
0.790.350.68-0.77-0.960.79-0.590.790.660.390.790.090.870.750.12-0.840.760.760.820.10.34-0.32-0.92-0.91-0.32
0.090.72-0.10.19-0.16-0.210.26-0.210.730.72-0.050.730.21-0.060.83-0.41-0.28-0.280.460.10.330.20.140.050.2
-0.110.77-0.310.18-0.47-0.12-0.34-0.120.210.77-0.14-0.170.32-0.20.69-0.440.540.540.450.340.33-0.04-0.38-0.52-0.04
-0.49-0.04-0.480.360.37-0.530.28-0.53-0.12-0.05-0.520.03-0.54-0.480.180.32-0.47-0.47-0.14-0.320.2-0.040.420.291.0
-0.69-0.26-0.610.740.94-0.780.71-0.78-0.42-0.3-0.730.15-0.79-0.67-0.010.76-0.92-0.92-0.69-0.920.14-0.380.420.970.42
-0.57-0.39-0.450.610.94-0.640.7-0.64-0.43-0.43-0.60.17-0.72-0.54-0.160.77-0.92-0.92-0.74-0.910.05-0.520.290.970.29
-0.49-0.04-0.480.360.37-0.530.28-0.53-0.12-0.05-0.520.03-0.54-0.480.180.32-0.47-0.47-0.14-0.320.2-0.041.00.420.29
Click cells to compare fundamentals

Telo Genomics Account Relationship Matchups

Telo Genomics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.2M3.8M2.8M2.9M3.4M3.5M
Total Current Liabilities353.4K113.7K190.1K280.4K322.4K362.7K
Total Stockholder Equity775.3K3.7M2.6M2.6M3.0M3.2M
Net Debt(881.0K)(3.6M)(2.7M)(2.6M)(2.4M)(2.3M)
Retained Earnings(19.1M)(20.2M)(22.3M)(25.1M)(22.6M)(21.5M)
Cash921.0K3.6M2.7M2.7M3.1M3.2M
Non Current Assets Total131.4K78.4K46.7K82.6K74.4K70.6K
Cash And Short Term Investments921.0K3.6M2.7M2.7M3.1M3.2M
Liabilities And Stockholders Equity1.2M3.8M2.8M2.9M3.4M3.5M
Other Stockholder Equity5.6M5.6M5.8M6.0M6.9M4.6M
Total Liab393.4K153.7K230.1K312.9K359.8K378.2K
Total Current Assets1.0M3.8M2.8M2.8M3.3M3.4M
Net Receivables49.3K96.7K38.0K63.8K57.4K67.7K
Common Stock Shares Outstanding29.9M46.9M58.7M60.2M69.2M72.6M
Net Tangible Assets(1.0M)643.9K3.6M2.6M3.0M3.1M
Accounts Payable1.0M353.4K102.4K190.0K171.0K162.5K
Common Stock14.3M18.2M19.1M21.7M24.9M13.3M
Property Plant Equipment179.7K115.0K62.1K22.9K20.6K19.6K
Property Plant And Equipment Net115.0K62.1K30.3K66.3K59.6K56.7K
Other Current Assets67.1K27.5K55.6K105.9K121.8K127.9K
Net Invested Capital815.3K3.7M2.6M2.6M3.0M1.7M
Net Working Capital683.9K3.6M2.6M2.6M2.9M3.1M
Capital Stock14.3M18.2M19.1M21.7M24.9M18.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Telo Stock Analysis

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.